BioMarin to Attend Upcoming Investor Conferences
- Bank of America Merrill Lynch 2016 Health Care Conference on May 11 in Las Vegas
- Goldman Sachs 37th Annual Global Healthcare Conference on June 9 in Ranchos Palos Verdes, California
SAN RAFAEL, Calif., May 04, 2016 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), today announced that Jean-Jacques Bienaimé, Chairman and Chief Executive Officer, will participate in the Bank of America Merrill Lynch 2016 Health Care Conference on May 11, 2016 at 10:00am PT/1:00pm ET, in Las Vegas and the Goldman Sachs 37th Annual Global Healthcare Conference on June 9, 2016 at 10:00am PT/1:00pm ET, in Ranchos Palos Verdes, California. To access the live webcasts, please visit the investor section of the BioMarin website, www.BMRN.com. A replay will also be archived on the site for at least one week following the event.
About BioMarin
BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company's portfolio consists of five commercialized products and multiple clinical and pre-clinical product candidates.
For additional information, please visit www.BMRN.com. Information on BioMarin's website is not incorporated by reference into this press release.
Contacts: Investors Traci McCarty BioMarin Pharmaceutical Inc. (415) 455-7558 Media Debra Charlesworth BioMarin Pharmaceutical Inc. (415) 455-7451
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
